This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Enrollment
70
Bilateral middle meningeal artery embolization using TRUFILL n-BCA liquid embolic system
John Muir Physician Network Clin. Research Center
Walnut Creek, California, United States
RECRUITINGHartford Hospital
Hartford, Connecticut, United States
RECRUITINGMount Sinai
New York, New York, United States
Change from baseline, in number of migraine days
Time frame: over 28 days post study intervention
Change from baseline in migraine days frequency
Time frame: 3 months and 6 months post study intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Stony Brook University Medical Center
Stony Brook, New York, United States
RECRUITINGThomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
RECRUITINGSemmes Murphey Foundation
Memphis, Tennessee, United States
RECRUITINGWest Virginia University
Morgantown, West Virginia, United States
RECRUITING